首页/数据集/Gene signature predictive of response to chemotherapy in mCRC [RT-PCR]

Gene signature predictive of response to chemotherapy in mCRC [RT-PCR]

ChEBI2013-11-20 更新2026-07-21 收录

化疗疗效评估

结直肠癌肝转移生物标志物

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-52513 数据链接链接失效反馈

官方服务：

资源简介：

Gene signature predictive of response to chemotherapy in mCRC [RT-PCR]

应用场景：

创建时间：

2013-11-20

结直肠癌肝转移生物标志物

瑞戈非尼疗效评估

This is an exploratory biomarker study. Patients with metastatic colorectal cancer will receive regorafenib, which is FDA approved in this setting, on day 1-21 of every consecutive 28 day cycle. Patie

NIAID Data Ecosystem100

Features summary of the eligible studies in the meta-analysis.

化疗疗效评估

化疗放疗方案

Abbreviations: HR, hazard ratio; OS, overall survival; EFS, event-free survival; IHC, immunohistochemistry; FISH, interphase fluorescent in situ hybridization; RT-PCR, reverse transcription-polymerase

NIAID Data Ecosystem50

Supplementary Data 1,4 from Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy

液体活检监测

化疗疗效评估

Supp Tables

NIAID Data Ecosystem30

Study on the Changes of Fecal Lipid Metabolites in Thyroid Cancer Patients Before and After Treatment

癌症代谢组学

化疗疗效评估

Study on the Changes of Fecal Lipid Metabolites in Thyroid Cancer Patients Before and After Treatment

NIAID Data Ecosystem60

Five-year survival rate according to hospital volume and surgeon volume (n = 11677).

化疗疗效评估

医疗质量分析

*Log-rank test for 5-year survival rates.†Cutoff point for hospital 65 cases for female breast cancer; 61 cases for colorectal cancer; 62 cases for lung cancer; 41 cases for prostate cancer; and 78 ca

Figshare2015-12-02 更新40

Gene signature predictive of response to chemotherapy in mCRC [RT-PCR]

资源简介：

相关数据集